Lipid Profile Alterations Across Coronary Heart Disease, Metabolic Syndrome, and Nephrotic Syndrome.

J Clin Lab Anal · 2026 · PMC13051875 · PMID 41787643

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

For CHD versus NS, ApoB remained significantly lower in CHD (OR = 0.028, p = 0.002), while the other LASSO‐selected markers did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.